A variation in a Pit-1 site in the growth hormone gene (GH1) promoter induces a differential transcriptional activity

Molecular and Cellular Endocrinology

Volumn 249, Issue 1-2, 2006, Pages 51-57

  Giordano, Mara ^a   Godi, Michela ^a   Giacopelli, Francesca ^b   Lessi, Monica ^a   Mellone, Simona ^a   Paracchini, Roberta ^a   Petri, Antonella ^a   Bellone, Jaele ^c   Ravazzolo, Roberto ^b   Bona, Gianni ^a   Momigliano Richiardi, Patricia ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

Author keywords

Growth hormone gene; Luciferase assay; Pit 1; Polymorphism

Indexed keywords

GROWTH HORMONE; LUCIFERASE; TRANSCRIPTION FACTOR PIT 1;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; ENZYME ACTIVITY; GEL MOBILITY SHIFT ASSAY; GENE STRUCTURE; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETIC VARIABILITY; GROWTH HORMONE RELEASE; HAPLOTYPE; HUMAN; HYPOPHYSIS CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; RAT;

ANIMALS; BINDING SITES; CELL LINE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENES, REPORTER; HAPLOTYPES; HUMAN GROWTH HORMONE; HUMANS; LUCIFERASES; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RATS; TRANSCRIPTION FACTOR PIT-1;

EID: 33646487589     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2006.01.006     Document Type: Article

References (28)

1. Bodner M., and Karin M. A pituitary-specific trans-acting factor can stimulate transcription from the growth hormone promoter in extracts of nonexpressing cells. Cell 50 (1987) 267-275
2. Chang W., Zhou W., Theill L.E., Baxter J.D., and Schaufele F. An activation function in Pit-1 required selectively for synergistic transcription. J. Biol. Chem. 271 (1996) 17733-17738
3. Cohen L.E., and Radovick S. Molecular basis of combined pituitary hormone deficiencies. Endocr. Rev. 23 (2002) 431-442
4. Courtois S.J., Lafontaine D.A., Lemaigre F.P., Durviaux S.M., and Rousseau G.G. Nuclear factor-I and activator protein-2 bind in a mutually exclusive way to overlapping promoter sequences and trans-activate the human growth hormone gene. Nucl. Acids Res. 18 (1990) 57-64
5. Dignam J.D., Lebovitz R.M., and Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucl. Acids Res. 11 (1983) 1475-1489
6. Elsholtz H.P., Albert V.R., Treacy M.N., and Rosenfeld M.G. A two-base change in a POU factor-binding site switches pituitary-specific to lymphoid-specific gene expression. Genes Dev. 4 (1990) 43-51
7. Ghigo E., Bellone J., Aimaretti G., Bellone S., Loche S., Cappa M., Bartolotta E., Dammacco F., and Camanni F. Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children. J. Clin. Endocr. Metab. 8 (1996) 3323-3327
8. Giordano M., Marchetti C., Chiorboli E., Bona G., and Momigliano-Richiardi P. Evidence for gene conversion in the generation of extensive polymorphism in the promoter of the growth hormone gene. Hum. Genet. 100 (1997) 249-255
9. Giordano M., Lessi M., Paracchini R., Petri A., Ozerkan E., Cavallo L., Wasniewska M., Aimaretti G., Momigliano-Richiardi P., and Bona G. Molecular analysis of the growth hormone gene (GH1) in isolated growth hormone deficiency. J. Endocr. Genet. 2 (2001) 45-54
10. Giustina A., and Veldhuis J.D. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr. Rev. 19 (1998) 717-797
11. Holloway J.M., Szeto D.P., Scully K.M., Glass C.K., and Rosenfeld M.G. Pit-1 binding to specific DNA sites as a monomer or dimer determines gene-specific use of a tyrosine-dependent synergy domain. Genes Dev. 15 (1995) 1992-2006
12. Horan M., Millar D.S., Hedderich J., Lewis G., Newsway V., Mo N., Fryklund L., Procter A.M., Krawczak M., and Cooper D.N. Human growth hormone 1 (GH1) gene expression: complex haplotype-dependent influence of polymorphic variation in the proximal promoter and locus control region. Hum. Mutat. 21 (2003) 408-423
13. Ingraham H.A., Chen R.P., Mangalam H.J., Elsholtz H.P., Flynn S.E., Lin C.R., Simmons D.M., Swanson L., and Rosenfeld M.G. A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype. Cell 55 (1988) 519-529
14. Ingraham H.A., Flynn S.E., Voss J.W., Albert V.R., Kapiloff M.S., Wilson L., and Rosenfeld M.G. The POU-specific domain of Pit-1 is essential for sequence-specific, high affinity DNA binding and DNA-dependent Pit-1-Pit-1 interactions. Cell 61 (1990) 1021-1233
15. Jones B.K., Monks B.R., Liebhaber S.A., and Cooke N.E. The human growth hormone gene is regulated by a multicomponent locus control region. Mol. Cell. Biol. 15 (1995) 7010-7021
16. Krawczak M., Chuzhanova N.A., and Cooper D.N. Evolution of the proximal promoter region of the mammalian growth hormone gene. Gene 237 (1999) 143-151
17. Lefevre C., Imagawa M., Dana S., Grindlay J., Bodner M., and Karin M. Tissue-specific expression of the human growth hormone gene is conferred in part by the binding of a specific trans-acting factor. EMBO J. 6 (1987) 971-981
18. Lemaigre F.P., Courtois S.J., Lafontaine D.A., and Rousseau G.G. Evidence that the upstream stimulatory factor and the Sp1 transcription factor bind in vitro to the promoter of the human-growth-hormone gene. Eur. J. Biochem. 181 (1989) 555-561
19. Lipkin S.M., Naar A.M., Kalla K.A., Sack R.A., and Rosenfeld M.G. Identification of a novel zinc finger protein binding a conserved element critical for Pit-1-dependent growth hormone gene expression. Genes Dev. 7 (1993) 1674-1687
20. Palomino T., Sanchez-Pacheco A., Pena P., and Aranda A.A. Direct protein-protein interaction is involved in the cooperation between thyroid hormone and retinoic acid receptors and the transcription factor GHF-1. FASEB J. 12 (1998) 1201-1209
21. Patrone G., Puliti A., Bocciardi R., Ravazzolo R., and Romeo G. Sequence and characterisation of the RET proto-oncogene 5′ flanking region: analysis of retinoic acid responsiveness at the transcriptional level. FEBS Lett. 419 (1997) 76-82
22. Salvatori R., Fan X., Mullis P.E., Haile A., and Levine M.A. Decreased expression of the GHRH receptor gene due to a mutation in a Pit-1 binding site. Mol. Endocrinol. 16 (2002) 450-458
23. Schaufele F., West B.L., and Baxter J.D. Synergistic activation of the rat growth hormone promoter by Pit-1 and the thyroid hormone receptor. Mol. Endocrinol. 6 (1992) 656-665
24. Scully K.M., Jacobson E.M., Jepsen K., Lunyak V., Viadiu H., Carriere C., Rose D.W., Hooshmand F., Aggarwal A.K., and Rosenfeld M.G. Allosteric effects of Pit-1 DNA sites on long-term repression in cell type specification. Science 290 (2000) 1127-1131
25. Seoane S., Alonso M., Segura C., and Perez-Fernandez R. Localization of a negative Vitamin D response sequence in the human growth hormone gene. Biochem. Biophys. Res. Commun. 292 (2002) 250-255
26. Shepard A.R., Zhang W., and Eberhardt N.L. Two CGTCA motifs and a GHF1/Pit1 binding site mediate cAMP-dependent protein kinase A regulation of human growth hormone gene expression in rat anterior pituitary GC cells. J. Biol. Chem. 269 (1994) 1804-1814
27. Shewchuk B.M., Liebhaber S.A., and Cooke N.E. Specification of unique Pit-1 activity in the hGH locus control region. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 11784-11789
28. Wagner J.K., Ebl A., Cogan J.D., Prince M.A., Phillips III J.A., and Mullis P.E. Allelic variations in the human growth hormone-1 gene promoter of growth hormone-deficient patients and normal controls. Eur. J. Endocrinol. 137 (1997) 474-481